logo
  • Home
  • Technologies
    • Live Cell Encapsulation
    • Research & Development
    • Cancer
    • Diabetes
    • Cannabinoids
  • Company
    • Management
    • Board of Directors
    • Governance
    • Medical and Scientific Advisory Board
    • International Diabetes Consortium
  • Investor Relations
    • Overview
    • News / Events
    • Shareholder Calls / Presentations
    • Company Information
    • Financial Information
    • Stock Data
    • SEC Filings
    • Corporate Governance
  • News
    • Press Releases
    • Articles
    • Reports
    • Media
    • Photo Gallery
  • Contact

Press Releases

Navigation Toggle Navigation
  • Overview
  • News / Events
    • Press Releases
    • IR Calendar
    • Email Alerts
  • Shareholder Calls / Presentations
  • Company Information
  • Financial Information
  • Stock Data
  • SEC Filings
  • Corporate Governance
  • Quick Links
  • Email Alerts
  • Tear Sheet
  • Contacts
  • RSS News Feed
  • All News
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • Oct 27, 2017

PharmaCyte Biotech Update on Shareholder Call

  • Oct 20, 2017

PharmaCyte Biotech to Hold Shareholder Call

  • Oct 17, 2017

PharmaCyte Biotech Research Identifies Enzyme Activity for Cannabinoid-Based Therapy to Fight Cancer

  • Oct 10, 2017

PharmaCyte Biotech Appoints Dr. Raymond Tong to Board of Directors

  • Sep 13, 2017

PharmaCyte Biotech Appoints Alan Morell of Creative Management Partners as Strategic Advisor

  • Sep 6, 2017

PharmaCyte Restructures Agreements with Austrianova to Strengthen Partnership

  • Jul 26, 2017

PharmaCyte Biotech Appoints Dr. Linda S. Sher as Chief Medical Officer

  • Jul 10, 2017

PharmaCyte Biotech Appoints Dr. Michael M. Abecassis to Board of Directors

  • Jul 6, 2017

PharmaCyte Biotech Releases Presentation to Oncologists and Interviews from 2017 ASCO Meeting Event

  • Jun 13, 2017

PharmaCyte Biotech to Present Pancreatic Cancer Therapy at 2017 BIO International Convention

RSS
  • « Previous
  • 1...
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • ...25
  • Next »

Contact Us

PharmaCyte Biotech, Inc.
23046 Avenida de la Carlota, Suite 600
Laguna Hills, California 92653
Office Number: 917.595.2850
Facsimile Number: 917.595.2851
Email: info@PharmaCyte.com

Latest News

  • PharmaCyte Biotech Begins DNA Sequence and Stability Studies in Response to FDA Requests for its Clinical Trial Product January 26, 2021
  • PharmaCyte Biotech Begins Physical Testing of CypCaps in Response to FDA Recommendations for its Clinical Trial Product December 14, 2020